Research progress on neonatal respiratory syncytial virus infection
10.3760/cma.j.issn.1673-4912.2020.10.009
- VernacularTitle:新生儿呼吸道合胞病毒感染的研究进展
- Author:
Hao CHEN
1
;
Jianhua FU
Author Information
1. 中国医科大学附属盛京医院儿内科，沈阳 110004
- From:
Chinese Pediatric Emergency Medicine
2020;27(10):754-757
- CountryChina
- Language:Chinese
-
Abstract:
Respiratory syncytial virus(RSV) is one of the most common pathogens causing viral pneumonia in neonates, especially among late neonates.Multiple clinical manifestations can be observed, such as cough, shortness of breath, and wheezing, with complications of heart failure or respiratory distress in severe cases.There is no specific treatment for RSV infection, thus current regimen is mainly supportive therapy focusing on symptoms.Premature infants are at higher risk of RSV infection than full-term infants given their immunocompromised status.In addition, an RSV infection history is a potential risk factor for future episodes of wheezing and bronchial asthma.A nosocomial spread of RSV may lead to an outbreak due to its high contagiousness therefore requiring utmost attention.
